MedTrace Logo

CoolSculpting System

NCT04506307 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2025-03-10

Study results available
· View outcomes & findings →

Summary

Evaluate the safety and efficacy of multiple, simultaneous CoolSculpting cycles for the purpose of non-invasive fat reduction.

Conditions

  • Body Fat Disorder

Interventions

DEVICE

The ZELTIQ System

The CoolSculpting machine will be used to perform the treatments.

Sponsors & Collaborators

  • Zeltiq Aesthetics

    lead INDUSTRY

Principal Investigators

  • Study Director · Zeltiq Aesthetics

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
22 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-03-13
Primary Completion
2022-08-24
Completion
2022-10-26
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04506307 on ClinicalTrials.gov